nodes	percent_of_prediction	percent_of_DWPC	metapath
Propantheline—Dermatitis atopic—Ibandronate—osteoporosis	0.0233	0.0233	CcSEcCtD
Propantheline—Dermatitis atopic—Risedronate—osteoporosis	0.0192	0.0192	CcSEcCtD
Propantheline—Thirst—Ibandronate—osteoporosis	0.0132	0.0132	CcSEcCtD
Propantheline—Thirst—Calcitriol—osteoporosis	0.0129	0.0129	CcSEcCtD
Propantheline—Confusional state—Calcium Acetate—osteoporosis	0.0114	0.0114	CcSEcCtD
Propantheline—Abdominal distension—Estropipate—osteoporosis	0.0114	0.0114	CcSEcCtD
Propantheline—Abdominal distension—Alendronate—osteoporosis	0.0112	0.0112	CcSEcCtD
Propantheline—Dysphagia—Alendronate—osteoporosis	0.0111	0.0111	CcSEcCtD
Propantheline—Dysphagia—Ibandronate—osteoporosis	0.0108	0.0108	CcSEcCtD
Propantheline—Constipation—Calcium Acetate—osteoporosis	0.00966	0.00966	CcSEcCtD
Propantheline—Drowsiness—Calcitriol—osteoporosis	0.00944	0.00944	CcSEcCtD
Propantheline—Thirst—Zoledronate—osteoporosis	0.00941	0.00941	CcSEcCtD
Propantheline—Feeling abnormal—Calcium Acetate—osteoporosis	0.00931	0.00931	CcSEcCtD
Propantheline—Abdominal distension—Ethinyl Estradiol—osteoporosis	0.00921	0.00921	CcSEcCtD
Propantheline—Abdominal distension—Risedronate—osteoporosis	0.00898	0.00898	CcSEcCtD
Propantheline—Constipation—Ergocalciferol—osteoporosis	0.00853	0.00853	CcSEcCtD
Propantheline—Hypersensitivity—Calcium Acetate—osteoporosis	0.00832	0.00832	CcSEcCtD
Propantheline—Flushing—Raloxifene—osteoporosis	0.00812	0.00812	CcSEcCtD
Propantheline—Asthenia—Calcium Acetate—osteoporosis	0.00811	0.00811	CcSEcCtD
Propantheline—Abdominal distension—Zoledronate—osteoporosis	0.0078	0.0078	CcSEcCtD
Propantheline—Dysphagia—Zoledronate—osteoporosis	0.00774	0.00774	CcSEcCtD
Propantheline—Tension—Estropipate—osteoporosis	0.00772	0.00772	CcSEcCtD
Propantheline—Nervousness—Estropipate—osteoporosis	0.00764	0.00764	CcSEcCtD
Propantheline—Abdominal distension—Conjugated Estrogens—osteoporosis	0.00751	0.00751	CcSEcCtD
Propantheline—Confusional state—Etidronic acid—osteoporosis	0.00748	0.00748	CcSEcCtD
Propantheline—Dizziness—Calcium Acetate—osteoporosis	0.00747	0.00747	CcSEcCtD
Propantheline—Dysphagia—Conjugated Estrogens—osteoporosis	0.00746	0.00746	CcSEcCtD
Propantheline—Vomiting—Calcium Acetate—osteoporosis	0.00718	0.00718	CcSEcCtD
Propantheline—Asthenia—Ergocalciferol—osteoporosis	0.00716	0.00716	CcSEcCtD
Propantheline—Palpitations—Estropipate—osteoporosis	0.00695	0.00695	CcSEcCtD
Propantheline—Nausea—Calcium Acetate—osteoporosis	0.00671	0.00671	CcSEcCtD
Propantheline—Palpitations—Ibandronate—osteoporosis	0.00666	0.00666	CcSEcCtD
Propantheline—Anaphylactic shock—Estropipate—osteoporosis	0.00642	0.00642	CcSEcCtD
Propantheline—Constipation—Etidronic acid—osteoporosis	0.00634	0.00634	CcSEcCtD
Propantheline—Flushing—Pamidronate—osteoporosis	0.0063	0.0063	CcSEcCtD
Propantheline—Dry mouth—Ibandronate—osteoporosis	0.00628	0.00628	CcSEcCtD
Propantheline—Anaphylactic shock—Ibandronate—osteoporosis	0.00615	0.00615	CcSEcCtD
Propantheline—Dry mouth—Calcitriol—osteoporosis	0.00615	0.00615	CcSEcCtD
Propantheline—Feeling abnormal—Etidronic acid—osteoporosis	0.00611	0.00611	CcSEcCtD
Propantheline—Anaphylactic shock—Calcitriol—osteoporosis	0.00602	0.00602	CcSEcCtD
Propantheline—Abdominal distension—Estradiol—osteoporosis	0.00601	0.00601	CcSEcCtD
Propantheline—Dysphagia—Estradiol—osteoporosis	0.00597	0.00597	CcSEcCtD
Propantheline—Nausea—Ergocalciferol—osteoporosis	0.00593	0.00593	CcSEcCtD
Propantheline—Urticaria—Etidronic acid—osteoporosis	0.00589	0.00589	CcSEcCtD
Propantheline—Insomnia—Estropipate—osteoporosis	0.0058	0.0058	CcSEcCtD
Propantheline—Tension—Pamidronate—osteoporosis	0.0058	0.0058	CcSEcCtD
Propantheline—Flushing—Zoledronate—osteoporosis	0.00575	0.00575	CcSEcCtD
Propantheline—Nervousness—Pamidronate—osteoporosis	0.00574	0.00574	CcSEcCtD
Propantheline—Somnolence—Estropipate—osteoporosis	0.0057	0.0057	CcSEcCtD
Propantheline—Insomnia—Raloxifene—osteoporosis	0.00562	0.00562	CcSEcCtD
Propantheline—Insomnia—Ibandronate—osteoporosis	0.00557	0.00557	CcSEcCtD
Propantheline—Constipation—Estropipate—osteoporosis	0.00549	0.00549	CcSEcCtD
Propantheline—Hypersensitivity—Etidronic acid—osteoporosis	0.00546	0.00546	CcSEcCtD
Propantheline—Insomnia—Calcitriol—osteoporosis	0.00545	0.00545	CcSEcCtD
Propantheline—Constipation—Alendronate—osteoporosis	0.0054	0.0054	CcSEcCtD
Propantheline—Somnolence—Calcitriol—osteoporosis	0.00536	0.00536	CcSEcCtD
Propantheline—Constipation—Ibandronate—osteoporosis	0.00526	0.00526	CcSEcCtD
Propantheline—Feeling abnormal—Alendronate—osteoporosis	0.00521	0.00521	CcSEcCtD
Propantheline—Dry mouth—Risedronate—osteoporosis	0.00517	0.00517	CcSEcCtD
Propantheline—Constipation—Calcitriol—osteoporosis	0.00515	0.00515	CcSEcCtD
Propantheline—Tension—Conjugated Estrogens—osteoporosis	0.0051	0.0051	CcSEcCtD
Propantheline—Urticaria—Estropipate—osteoporosis	0.0051	0.0051	CcSEcCtD
Propantheline—Vision blurred—Zoledronate—osteoporosis	0.00508	0.00508	CcSEcCtD
Propantheline—Feeling abnormal—Ibandronate—osteoporosis	0.00507	0.00507	CcSEcCtD
Propantheline—Nervousness—Conjugated Estrogens—osteoporosis	0.00505	0.00505	CcSEcCtD
Propantheline—Urticaria—Alendronate—osteoporosis	0.00502	0.00502	CcSEcCtD
Propantheline—Vision blurred—Conjugated Estrogens—osteoporosis	0.0049	0.0049	CcSEcCtD
Propantheline—Urticaria—Ibandronate—osteoporosis	0.00489	0.00489	CcSEcCtD
Propantheline—Confusional state—Pamidronate—osteoporosis	0.00486	0.00486	CcSEcCtD
Propantheline—Anaphylactic shock—Pamidronate—osteoporosis	0.00482	0.00482	CcSEcCtD
Propantheline—Urticaria—Calcitriol—osteoporosis	0.00479	0.00479	CcSEcCtD
Propantheline—Palpitations—Zoledronate—osteoporosis	0.00477	0.00477	CcSEcCtD
Propantheline—Hypersensitivity—Estropipate—osteoporosis	0.00473	0.00473	CcSEcCtD
Propantheline—Vomiting—Etidronic acid—osteoporosis	0.00472	0.00472	CcSEcCtD
Propantheline—Tachycardia—Pamidronate—osteoporosis	0.00471	0.00471	CcSEcCtD
Propantheline—Rash—Etidronic acid—osteoporosis	0.00468	0.00468	CcSEcCtD
Propantheline—Dermatitis—Etidronic acid—osteoporosis	0.00467	0.00467	CcSEcCtD
Propantheline—Hypersensitivity—Alendronate—osteoporosis	0.00466	0.00466	CcSEcCtD
Propantheline—Headache—Etidronic acid—osteoporosis	0.00465	0.00465	CcSEcCtD
Propantheline—Asthenia—Estropipate—osteoporosis	0.0046	0.0046	CcSEcCtD
Propantheline—Palpitations—Conjugated Estrogens—osteoporosis	0.00459	0.00459	CcSEcCtD
Propantheline—Insomnia—Risedronate—osteoporosis	0.00459	0.00459	CcSEcCtD
Propantheline—Asthenia—Alendronate—osteoporosis	0.00453	0.00453	CcSEcCtD
Propantheline—Hypersensitivity—Ibandronate—osteoporosis	0.00453	0.00453	CcSEcCtD
Propantheline—Dry mouth—Zoledronate—osteoporosis	0.00449	0.00449	CcSEcCtD
Propantheline—Constipation—Ethinyl Estradiol—osteoporosis	0.00445	0.00445	CcSEcCtD
Propantheline—Confusional state—Zoledronate—osteoporosis	0.00444	0.00444	CcSEcCtD
Propantheline—Hypersensitivity—Calcitriol—osteoporosis	0.00444	0.00444	CcSEcCtD
Propantheline—Flushing—Estradiol—osteoporosis	0.00443	0.00443	CcSEcCtD
Propantheline—Asthenia—Ibandronate—osteoporosis	0.00442	0.00442	CcSEcCtD
Propantheline—Nausea—Etidronic acid—osteoporosis	0.00441	0.00441	CcSEcCtD
Propantheline—Anaphylactic shock—Zoledronate—osteoporosis	0.0044	0.0044	CcSEcCtD
Propantheline—Insomnia—Pamidronate—osteoporosis	0.00436	0.00436	CcSEcCtD
Propantheline—Constipation—Risedronate—osteoporosis	0.00434	0.00434	CcSEcCtD
Propantheline—Asthenia—Calcitriol—osteoporosis	0.00432	0.00432	CcSEcCtD
Propantheline—Tachycardia—Zoledronate—osteoporosis	0.0043	0.0043	CcSEcCtD
Propantheline—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.00429	0.00429	CcSEcCtD
Propantheline—Somnolence—Pamidronate—osteoporosis	0.00429	0.00429	CcSEcCtD
Propantheline—Dizziness—Estropipate—osteoporosis	0.00424	0.00424	CcSEcCtD
Propantheline—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00424	0.00424	CcSEcCtD
Propantheline—Dizziness—Alendronate—osteoporosis	0.00418	0.00418	CcSEcCtD
Propantheline—Tachycardia—Conjugated Estrogens—osteoporosis	0.00414	0.00414	CcSEcCtD
Propantheline—Urticaria—Ethinyl Estradiol—osteoporosis	0.00413	0.00413	CcSEcCtD
Propantheline—Constipation—Pamidronate—osteoporosis	0.00412	0.00412	CcSEcCtD
Propantheline—Dizziness—Raloxifene—osteoporosis	0.00411	0.00411	CcSEcCtD
Propantheline—Tension—Estradiol—osteoporosis	0.00408	0.00408	CcSEcCtD
Propantheline—Vomiting—Estropipate—osteoporosis	0.00408	0.00408	CcSEcCtD
Propantheline—Dizziness—Ibandronate—osteoporosis	0.00407	0.00407	CcSEcCtD
Propantheline—Rash—Estropipate—osteoporosis	0.00405	0.00405	CcSEcCtD
Propantheline—Dermatitis—Estropipate—osteoporosis	0.00404	0.00404	CcSEcCtD
Propantheline—Nervousness—Estradiol—osteoporosis	0.00404	0.00404	CcSEcCtD
Propantheline—Urticaria—Risedronate—osteoporosis	0.00403	0.00403	CcSEcCtD
Propantheline—Headache—Estropipate—osteoporosis	0.00402	0.00402	CcSEcCtD
Propantheline—Vomiting—Alendronate—osteoporosis	0.00402	0.00402	CcSEcCtD
Propantheline—Rash—Alendronate—osteoporosis	0.00399	0.00399	CcSEcCtD
Propantheline—Insomnia—Zoledronate—osteoporosis	0.00398	0.00398	CcSEcCtD
Propantheline—Dermatitis—Alendronate—osteoporosis	0.00398	0.00398	CcSEcCtD
Propantheline—Feeling abnormal—Pamidronate—osteoporosis	0.00397	0.00397	CcSEcCtD
Propantheline—Headache—Alendronate—osteoporosis	0.00396	0.00396	CcSEcCtD
Propantheline—Vomiting—Raloxifene—osteoporosis	0.00395	0.00395	CcSEcCtD
Propantheline—Rash—Raloxifene—osteoporosis	0.00392	0.00392	CcSEcCtD
Propantheline—Dermatitis—Raloxifene—osteoporosis	0.00392	0.00392	CcSEcCtD
Propantheline—Somnolence—Zoledronate—osteoporosis	0.00391	0.00391	CcSEcCtD
Propantheline—Vomiting—Ibandronate—osteoporosis	0.00391	0.00391	CcSEcCtD
Propantheline—Headache—Raloxifene—osteoporosis	0.00389	0.00389	CcSEcCtD
Propantheline—Rash—Ibandronate—osteoporosis	0.00388	0.00388	CcSEcCtD
Propantheline—Dermatitis—Ibandronate—osteoporosis	0.00388	0.00388	CcSEcCtD
Propantheline—Headache—Ibandronate—osteoporosis	0.00385	0.00385	CcSEcCtD
Propantheline—Insomnia—Conjugated Estrogens—osteoporosis	0.00383	0.00383	CcSEcCtD
Propantheline—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00383	0.00383	CcSEcCtD
Propantheline—Vomiting—Calcitriol—osteoporosis	0.00383	0.00383	CcSEcCtD
Propantheline—Nausea—Estropipate—osteoporosis	0.00381	0.00381	CcSEcCtD
Propantheline—Rash—Calcitriol—osteoporosis	0.0038	0.0038	CcSEcCtD
Propantheline—Dermatitis—Calcitriol—osteoporosis	0.00379	0.00379	CcSEcCtD
Propantheline—Headache—Calcitriol—osteoporosis	0.00377	0.00377	CcSEcCtD
Propantheline—Somnolence—Conjugated Estrogens—osteoporosis	0.00377	0.00377	CcSEcCtD
Propantheline—Constipation—Zoledronate—osteoporosis	0.00377	0.00377	CcSEcCtD
Propantheline—Nausea—Alendronate—osteoporosis	0.00375	0.00375	CcSEcCtD
Propantheline—Hypersensitivity—Risedronate—osteoporosis	0.00374	0.00374	CcSEcCtD
Propantheline—Asthenia—Ethinyl Estradiol—osteoporosis	0.00373	0.00373	CcSEcCtD
Propantheline—Nausea—Raloxifene—osteoporosis	0.00369	0.00369	CcSEcCtD
Propantheline—Palpitations—Estradiol—osteoporosis	0.00367	0.00367	CcSEcCtD
Propantheline—Nausea—Ibandronate—osteoporosis	0.00366	0.00366	CcSEcCtD
Propantheline—Asthenia—Risedronate—osteoporosis	0.00364	0.00364	CcSEcCtD
Propantheline—Feeling abnormal—Zoledronate—osteoporosis	0.00363	0.00363	CcSEcCtD
Propantheline—Constipation—Conjugated Estrogens—osteoporosis	0.00363	0.00363	CcSEcCtD
Propantheline—Nausea—Calcitriol—osteoporosis	0.00358	0.00358	CcSEcCtD
Propantheline—Hypersensitivity—Pamidronate—osteoporosis	0.00355	0.00355	CcSEcCtD
Propantheline—Urticaria—Zoledronate—osteoporosis	0.0035	0.0035	CcSEcCtD
Propantheline—Dry mouth—Estradiol—osteoporosis	0.00346	0.00346	CcSEcCtD
Propantheline—Asthenia—Pamidronate—osteoporosis	0.00346	0.00346	CcSEcCtD
Propantheline—Dizziness—Ethinyl Estradiol—osteoporosis	0.00344	0.00344	CcSEcCtD
Propantheline—Confusional state—Estradiol—osteoporosis	0.00342	0.00342	CcSEcCtD
Propantheline—Anaphylactic shock—Estradiol—osteoporosis	0.00339	0.00339	CcSEcCtD
Propantheline—Urticaria—Conjugated Estrogens—osteoporosis	0.00337	0.00337	CcSEcCtD
Propantheline—Dizziness—Risedronate—osteoporosis	0.00335	0.00335	CcSEcCtD
Propantheline—Tachycardia—Estradiol—osteoporosis	0.00331	0.00331	CcSEcCtD
Propantheline—Vomiting—Ethinyl Estradiol—osteoporosis	0.00331	0.00331	CcSEcCtD
Propantheline—Rash—Ethinyl Estradiol—osteoporosis	0.00328	0.00328	CcSEcCtD
Propantheline—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00328	0.00328	CcSEcCtD
Propantheline—Headache—Ethinyl Estradiol—osteoporosis	0.00326	0.00326	CcSEcCtD
Propantheline—Hypersensitivity—Zoledronate—osteoporosis	0.00324	0.00324	CcSEcCtD
Propantheline—Vomiting—Risedronate—osteoporosis	0.00322	0.00322	CcSEcCtD
Propantheline—Rash—Risedronate—osteoporosis	0.0032	0.0032	CcSEcCtD
Propantheline—Dermatitis—Risedronate—osteoporosis	0.00319	0.00319	CcSEcCtD
Propantheline—Dizziness—Pamidronate—osteoporosis	0.00319	0.00319	CcSEcCtD
Propantheline—Headache—Risedronate—osteoporosis	0.00318	0.00318	CcSEcCtD
Propantheline—Asthenia—Zoledronate—osteoporosis	0.00316	0.00316	CcSEcCtD
Propantheline—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00312	0.00312	CcSEcCtD
Propantheline—Nausea—Ethinyl Estradiol—osteoporosis	0.00309	0.00309	CcSEcCtD
Propantheline—Insomnia—Estradiol—osteoporosis	0.00307	0.00307	CcSEcCtD
Propantheline—Vomiting—Pamidronate—osteoporosis	0.00307	0.00307	CcSEcCtD
Propantheline—Asthenia—Conjugated Estrogens—osteoporosis	0.00304	0.00304	CcSEcCtD
Propantheline—Rash—Pamidronate—osteoporosis	0.00304	0.00304	CcSEcCtD
Propantheline—Dermatitis—Pamidronate—osteoporosis	0.00304	0.00304	CcSEcCtD
Propantheline—Headache—Pamidronate—osteoporosis	0.00302	0.00302	CcSEcCtD
Propantheline—Somnolence—Estradiol—osteoporosis	0.00302	0.00302	CcSEcCtD
Propantheline—Nausea—Risedronate—osteoporosis	0.00301	0.00301	CcSEcCtD
Propantheline—Dizziness—Zoledronate—osteoporosis	0.00291	0.00291	CcSEcCtD
Propantheline—Constipation—Estradiol—osteoporosis	0.0029	0.0029	CcSEcCtD
Propantheline—Nausea—Pamidronate—osteoporosis	0.00286	0.00286	CcSEcCtD
Propantheline—Dizziness—Conjugated Estrogens—osteoporosis	0.0028	0.0028	CcSEcCtD
Propantheline—Vomiting—Zoledronate—osteoporosis	0.0028	0.0028	CcSEcCtD
Propantheline—Feeling abnormal—Estradiol—osteoporosis	0.0028	0.0028	CcSEcCtD
Propantheline—Rash—Zoledronate—osteoporosis	0.00278	0.00278	CcSEcCtD
Propantheline—Dermatitis—Zoledronate—osteoporosis	0.00277	0.00277	CcSEcCtD
Propantheline—Headache—Zoledronate—osteoporosis	0.00276	0.00276	CcSEcCtD
Propantheline—Vomiting—Conjugated Estrogens—osteoporosis	0.0027	0.0027	CcSEcCtD
Propantheline—Urticaria—Estradiol—osteoporosis	0.0027	0.0027	CcSEcCtD
Propantheline—Rash—Conjugated Estrogens—osteoporosis	0.00267	0.00267	CcSEcCtD
Propantheline—Dermatitis—Conjugated Estrogens—osteoporosis	0.00267	0.00267	CcSEcCtD
Propantheline—Headache—Conjugated Estrogens—osteoporosis	0.00266	0.00266	CcSEcCtD
Propantheline—Nausea—Zoledronate—osteoporosis	0.00262	0.00262	CcSEcCtD
Propantheline—Nausea—Conjugated Estrogens—osteoporosis	0.00252	0.00252	CcSEcCtD
Propantheline—Hypersensitivity—Estradiol—osteoporosis	0.0025	0.0025	CcSEcCtD
Propantheline—Asthenia—Estradiol—osteoporosis	0.00243	0.00243	CcSEcCtD
Propantheline—Dizziness—Estradiol—osteoporosis	0.00224	0.00224	CcSEcCtD
Propantheline—Vomiting—Estradiol—osteoporosis	0.00216	0.00216	CcSEcCtD
Propantheline—Rash—Estradiol—osteoporosis	0.00214	0.00214	CcSEcCtD
Propantheline—Dermatitis—Estradiol—osteoporosis	0.00214	0.00214	CcSEcCtD
Propantheline—Headache—Estradiol—osteoporosis	0.00213	0.00213	CcSEcCtD
Propantheline—Nausea—Estradiol—osteoporosis	0.00202	0.00202	CcSEcCtD
